Proprotein convertase subtilisin/kexin type 9 (PCSK9) association to LDL in patients treated with anti-PCSK9 monoclonal antibodies. (August 2021) - Canclini, L.; Jabnati, N.; Malvandi, A.M.; Baragetti, A.; Grigore, L.; Catapano, A.L.